Differential effects of antiepileptic drugs on human bone cells

被引:15
|
作者
Rocha, Sara [1 ,2 ,3 ]
Ferraz, Ricardo [2 ,3 ,4 ]
Prudencio, Cristina [2 ,3 ,5 ]
Fernandes, Maria Helena [1 ,4 ]
Costa-Rodrigues, Joao [1 ,5 ,6 ,7 ]
机构
[1] Univ Porto, Fac Dent Med, Lab Bone Metab & Regenerat, Porto, Portugal
[2] Inst Politecn Porto, Escola Super Saude, CQB, Porto, Portugal
[3] Inst Politecn Porto, Escola Super Saude, CISA, Porto, Portugal
[4] Univ Porto, REQUIMTE LAQV, Porto, Portugal
[5] Univ Porto, i3S, Inst Inovacao & Invest Saude, Porto, Portugal
[6] ESS, Porto, Portugal
[7] Escola Super Saude, Inst Politecn Viana Castelo, Porto, Portugal
关键词
antiepileptic drugs; osteoblastogenesis; osteoclastogenesis; LONG-TERM VALPROATE; MINERAL DENSITY; PLASMA-CONCENTRATION; PEDIATRIC-PATIENTS; METABOLISM; CHILDREN; ACID; CARBAMAZEPINE; TOPIRAMATE; TURNOVER;
D O I
10.1002/jcp.28569
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Antiepileptic drugs (AED) have been associated to in vivo deleterious consequences in bone tissue. The present work aimed to characterize the cellular and molecular effects of five different AED on human osteoclastogenesis and osteblastogenesis. It was observed that the different drugs had the ability to differentially modulate both processes, in a way dependent on the identity and dose of the AED. Shortly, valproic acid stimulated either osteoclastogenesis and osteoblastogenesis, whereas carbamazepine, gabapentin, and lamotrigine revealed an opposite behavior; topiramate elicited a decrease of osteoclast development and an increase in osteoblast differentiation. This is the first report describing the direct effects of different AED on human primary bone cells, which is a very important issue, because these drugs are usually consumed in long-term therapeutics, with acknowledged in vivo effects in bone tissue.
引用
收藏
页码:19691 / 19701
页数:11
相关论文
共 50 条
  • [21] Bone mineral changes and antiepileptic drugs
    Bento, C
    Lourenço, C
    Nunes, J
    Morgadinho, AS
    Geraldo, A
    Rodrigues, J
    Pereira, L
    Sales, F
    Lima, J
    EPILEPSIA, 2005, 46 : 99 - 99
  • [22] Bone and calcium metabolism and antiepileptic drugs
    Verrotti, Alberto
    Coppola, Giangennaro
    Parisi, Pasquale
    Mohn, Angelika
    Chiarelli, Francesco
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2010, 112 (01) : 1 - 10
  • [23] Effects of Antiepileptic Drugs on Bone Health and Growth Potential in Children with Epilepsy
    Vestergaard, Peter
    PEDIATRIC DRUGS, 2015, 17 (02) : 141 - 150
  • [24] Antiepileptic drugs and bone mass in menopause
    Antonelli, L.
    Rudez, J.
    Antoèiæ, I.
    Perkoviæ, O.
    Popoviæ, K.
    Cvjetoviæ, D.
    EPILEPSIA, 2006, 47 : 118 - 119
  • [25] Adverse Effects of Antiepileptic Drugs on Bone StructureEpidemiology, Mechanisms and Therapeutic Implications
    Alison M. Pack
    Martha J. Morrell
    CNS Drugs, 2001, 15 : 633 - 642
  • [26] Effects of Antiepileptic Drugs on Bone Health and Growth Potential in Children with Epilepsy
    Peter Vestergaard
    Pediatric Drugs, 2015, 17 : 141 - 150
  • [27] EFFECTS OF THE ANTIEPILEPTIC DRUGS CARBAMAZEPINE AND LEVETIRACETAM ON BONE HEALING IN RAT FRACTURE
    Tikman, Mesut
    Duman, Evrim
    NOBEL MEDICUS, 2024, 20 (02): : 119 - 127
  • [28] Effects of antiepileptic drugs on the human fetal testis ex vivo
    Lesne, L.
    Desdoits, C.
    Hug, E.
    Toupin, M.
    Kugathas, I.
    Raffenne, L.
    Costet, N.
    Lavoue, V.
    Chalmel, F.
    Jegou, B.
    Mazaud-Guittot, S.
    TOXICOLOGY LETTERS, 2022, 368 : S114 - S114
  • [29] Antiepileptic drugs as human teratogens
    Eadie, Mervyn J.
    EXPERT OPINION ON DRUG SAFETY, 2008, 7 (02) : 195 - 209
  • [30] Effects of the Antiepileptic Drugs Phenytoin, Gabapentin, and Levetiracetam on Bone Strength, Bone Mass, and Bone Turnover in Rats
    Kanda, Junkichi
    Izumo, Nobuo
    Kobayashi, Yoshiko
    Onodera, Kenji
    Shimakura, Taketoshi
    Yamamoto, Noriaki
    Takahashi, Hideaki E.
    Wakabayashi, Hiroyuki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (11) : 1934 - 1940